Combined and Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2015	Jul. 31, 2014	Jul. 31, 2013
Operating activities:
Net (loss) income	$ (2,076)	$ 2,069	$ (3,612)
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Common stock issued or to be issued for compensation	3,347	$ 746
Gain from sale of patent	(35)
Stock-based compensation		$ 12	$ 675
Deferred income taxes	2,809	(2,809)
Changes in assets and liabilities:
Trade accounts receivable, net	(21)	(1)	$ (23)
Prepaid expenses - related to settlements and licensing	4,977	(5,760)
Other current assets	(181)	(2)	$ (149)
Other assets	20	104
Trade accounts payable	238	(1)
Accrued expenses	(538)	(139)	$ 305
Due to IDT Corporation	(6)	6
Deferred revenue	(10,179)	11,535	$ 172
Income taxes payable	(245)	455	(5)
Net cash (used in) provided by operating activities	(1,890)	$ 6,215	(2,637)
Investing activities:
Purchase of intangibles	(15)		$ (350)
Proceeds from sale of patent	35
Net cash provided by (used in) investing activities	20		$ (350)
Financing activities:
Sale of treasury stock	65
Common stock issued upon exercise of stock options	68	$ 17
Dividends paid to stockholders of noncontrolling interests	$ (875)
Funding provided by IDT Corporation, net of repayments			$ 15,389
Net cash (used in) provided by financing activities	$ (742)	$ 17	15,389
Net (decrease) increase in cash and cash equivalents	(2,612)	6,232	12,402
Cash and cash equivalents at beginning of year	21,232	15,000	2,598
Cash and cash equivalents at end of year	18,620	$ 21,232	$ 15,000
Supplemental schedule of noncash activities
Common stock repurchased for withholding tax purposes	545
Reversal of prior period related party payables	513
Supplemental cash flow information
Cash paid during the year for income taxes	$ 119